Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05823090 · ClinicalTrials.gov registry record · Phase 4
Light Therapy for Depression in Adolescent Outpatients
A Phase 4 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT05823090: Completed Phase 4 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT05823090 is a Phase 4 study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 9 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05823090, a Phase 4 study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
The goal of this placebo lead-in clinical trial was to test bright light therapy (BLT) in adolescents with depression. The main question\[s\] it aimed to answer were: 1. characterize and define facilitators/barriers to treatment with BLT in adolescents); 2. evaluate the acceptability and feasibility of outpatient BLT in a dose titration protocol; 3. establish an effective, safe and tolerable light dose.
Primary Outcome
Adherence to prescribed daily light box use measured by days used as a percentage of days prescribed.
Interventions
- DEVICE light box (Carex DayLight Classic Model)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-12-21 |
| Est. Completion | 2022-11-08 |
| Phase | Phase 4 |
What the finished NCT05823090 record still lists
NCT05823090 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which light box (Carex DayLight Classic Model) is the first listed.
NCT05823090 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05823090 about?
NCT05823090 is a clinical study titled "Light Therapy for Depression in Adolescent Outpatients". The goal of this placebo lead-in clinical trial was to test bright light therapy (BLT) in adolescents with depression. The main question\[s\] it aimed to answer were: 1. characterize and define facilitators/barriers to treatment with BLT in adolescents); 2. evaluate the acceptability and feasibilit...
What is the current status of trial NCT05823090?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2021-12-21. Estimated completion is 2022-11-08.
What interventions are being tested in trial NCT05823090?
The interventions under investigation include: light box (Carex DayLight Classic Model) (DEVICE).
Who is sponsoring clinical trial NCT05823090?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05823090's enrollment target sits among peer trials
9 1968th of 2000 higher than 29 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI